Antiandrogens

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3156

Patent

active

060158069

ABSTRACT:
Androgen nucleus derivatives having specified substituents at the 17.alpha. position are disclosed for use as antiandrogens for the treatment of androgen-dependent diseases. In some preferred embodiments, the compound ##STR1## is formulated together with pharmaceutically acceptable diluent or carrier for topical use in the treatment of androgen-dependent diseases associated with the skin.

REFERENCES:
patent: 4039669 (1977-08-01), Beylen et al.
patent: 5132106 (1992-07-01), Tuloup et al.
patent: 5364847 (1994-11-01), Labrie et al.
Weikel, et al., Journal of Toxicology & Environ. Health, 3:167-177 (1977).
Thornber, Chemical Society Reviews 8(4): 563-580 (1979).
Salman, et al., J. Steroid Biochem 33(1):25-31 (1989).
Patent Abstracts of Japan, 4(38), JP Appln. 790077047, (1980).
Declaration from file wrapper of Republic of China (Taiwan) application 9106669 published Apr. 11, 1992 and English basis.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antiandrogens does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiandrogens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiandrogens will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-563635

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.